These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6278174)

  • 21. [Laboratory and clinical studies of cefmenoxime in the pediatric field].
    Sekiguchi T; Miyao M; Kokawa T; Uyama Y; Mizui M; Tanaka H
    Jpn J Antibiot; 1982 Nov; 35(11):2570-7. PubMed ID: 6302338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibacterial activity of cefotiam against clinical isolates in the field of obstetrics and gynecology].
    Deguchi K
    Jpn J Antibiot; 1983 Apr; 36(4):678-88. PubMed ID: 6308295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical laboratory approach for estimating effective administrative dosage of cefmenoxime. Observation on the MICS and cefmenoxime disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1984 May; 37(5):791-801. PubMed ID: 6090721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibacterial activities of monobactams against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antimicrobial activity of cefodizime against clinical isolates].
    Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Deguchi K; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Oct; 49(10):947-65. PubMed ID: 8986558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fundamental and clinical studies on cefuzoname in the pediatric field].
    Toyonaga Y; Sugita M; Kawamura K; Seo K; Takahashi T; Hori M
    Jpn J Antibiot; 1987 Apr; 40(4):843-65. PubMed ID: 3613094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
    Deguchi K; Oda S; Sato Y; Ikeda Y; Nakamura T
    Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on the drug sensitivity of multiple drug-resistant Staphylococcus aureus].
    Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Satoh K; Toyonaga Y
    Jpn J Antibiot; 1985 Aug; 38(8):2163-70. PubMed ID: 3852898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). I. Susceptibility distribution].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1989 Oct; 42(10):2141-73. PubMed ID: 2691714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic effects of cefmenoxime in the treatment of various infections on infants and children].
    Kurashige T; Wakiguchi H; Kitamura I; Ozaki H; Nishibayashi Y; Hamawaki M
    Jpn J Antibiot; 1982 Nov; 35(11):2579-88. PubMed ID: 6302339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
    Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibacterial activities of cefmenoxime against recent fresh clinical isolates from patients in sinusitis].
    Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Deguchi K; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 May; 48(5):602-9. PubMed ID: 7637194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Okayama S; Shigeta S; Shiraiwa Y; Yoshida H; Miura Y; Ogata M
    Jpn J Antibiot; 1987 Dec; 40(12):2026-142. PubMed ID: 3448256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro susceptibility of bacterial isolates from patients with respiratory tract infections to beta-lactam antibiotics].
    Otsuki M; Tanaka M; Saji Y; Nishino T; Tanino T; Nakanishi M; Maekawa N; Yoshikawa T; Fukumoto K; Kondo M
    Jpn J Antibiot; 1986 Mar; 39(3):772-82. PubMed ID: 3735668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro antimicrobial activity of various antibiotics against Haemophilus influenzae isolated from clinical specimens in 1983].
    Matsuo K; Uete T
    Jpn J Antibiot; 1985 Jun; 38(6):1685-92. PubMed ID: 3876455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fundamental and clinical studies on cefuzonam in the field of pediatrics].
    Kuno K; Hakamada S; Miyachi Y; Nakashima T; Hayakawa F; Miura K; Miyajima Y
    Jpn J Antibiot; 1987 Feb; 40(2):405-18. PubMed ID: 3599389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.